Macrogol (Polyethylene Glycol)
Brand names: Klean-Prep, Moviprep, Laxido
Macrogol (polyethylene glycol) is an osmotic laxative used in the surgical setting to treat constipation and faecal loading and to relieve opioid-induced constipation after operations.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
As an inert, non-absorbed polymer it sequesters water within the bowel lumen by osmosis, increasing stool water content and volume to soften faeces and promote peristalsis.
Prescribing in practice
- Do not use where intestinal obstruction, perforation, ileus or another acute surgical abdomen is suspected, as osmotic laxatives are hazardous in these settings; ensure mechanical obstruction is excluded before treating post-operative constipation.
- Dissolve each sachet in water as directed and maintain adequate fluid intake; higher regimens used for faecal impaction deliver a substantial fluid and electrolyte load.
- Use cautiously in patients with cardiovascular impairment or fluid-balance concerns when large-volume regimens are given.
Monitoring
Monitor bowel response and, when high-volume regimens are used or in frail patients, fluid balance and electrolytes.
Counselling the patient
- Mix each sachet with water as instructed and keep drinking fluids while taking it.
- Stop and seek advice if you develop abdominal pain, bloating or vomiting.
Evidence & guidelines
Macrogols are first-line osmotic laxatives with good evidence in chronic constipation and faecal impaction; the SPC contraindicates them in obstruction and perforation.
Reference: Moviprep SPC; BSG Bowel Preparation Guidelines; NICE NG90 (Childhood Constipation); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Osmol Gap · Renal / Metabolic
- Harvey-Bradshaw Index for Crohn's Disease · Inflammatory Bowel Disease
- Mayo Score for Ulcerative Colitis Activity · Inflammatory Bowel Disease
- Rome IV Criteria for Irritable Bowel Syndrome · Functional GI
- Crohn's Disease Activity Index (CDAI) · Inflammatory Bowel Disease
- Truelove and Witts Severity Index for Ulcerative Colitis · Inflammatory Bowel Disease
- Major Trauma — Primary Survey (ATLS) · ATLS 10th Edition; JRCALC; NICE NG39
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Burns — TBSA Estimation & Fluid Resuscitation · British Burn Association; EMSB; RCEM 2024
- Lower Gastrointestinal Bleed · NICE; BSG; ACPGBI — Commissioning Guide
- Acute Pancreatitis · NICE; IAP/APA; ACPGBI — CG104
- Hypertrophic Pyloric Stenosis · BAPS / RCPCH